Physician profile
Kyle Tryon
NPI 1689331522
$2,294.30
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $265 · 2022: $1,696 · 2023: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $315.91 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $305.44 | 2021-2023 | Brilinta |
| Janssen Pharmaceuticals, INC | $280.82 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.49 | 2022-2023 | Jardiance, Spiriva Respimat |
| Novartis Pharmaceuticals Corporation | $229.55 | 2022 | |
| Merck Sharp & Dohme LLC | $201.67 | 2022-2023 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $190.44 | 2022-2023 | |
| Lilly USA, LLC | $151.36 | 2022-2023 | Mounjaro, Trulicity |
| Esperion Therapeutics, INC. | $124.99 | 2021 | |
| Pfizer INC. | $105.56 | 2022-2023 | |
| Axsome Therapeutics, INC. | $43.58 | 2022-2023 | Sunosi |
| Jazz Pharmaceuticals INC. | $41.87 | 2021-2022 | |
| Abbvie INC. | $20.23 | 2022 | |
| Amgen INC. | $20.13 | 2022 | |
| Currax Pharmaceuticals LLC | $15.94 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Tryon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.